Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evelyn Walter

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 14, 2018
Introduction and OverviewEvelyn Walter
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 14, 2018
Approaches to Capturing Value in OncologyEvelyn Walter
Multiple Sclerosis and Related Disorders|April 21, 2015
Socio-economic aspects of the testing for antibodies in MS-patients under interferon therapy in Austria: a cost of illness studyEvelyn Walter, Florian Deisenhammer
Journal of Medical Economics|October 29, 2014
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and GermanyEvelyn Walter, Per Odin
Journal of Cardiothoracic and Vascular Anesthesia|December 16, 2019
Cost-Effectiveness Analysis of Landiolol, an Ultrashort-Acting Beta-Blocker, for Prevention of Postoperative Atrial Fibrillation for the Germany Health Care SystemEvelyn Walter, Matthias Heringlake
Wiener Medizinische Wochenschrift (1946)|January 11, 2007
[Theoretical implications of health economic evaluations in an Austrian context]Evelyn Walter, Susanne Zehetmayr
Wiener Medizinische Wochenschrift (1946)|May 27, 2008
[Cost of medications in the oncology sector in the context of health economics]Evelyn Walter, Anamarija Batista
Wiener Medizinische Wochenschrift (1946)|January 11, 2007
[Guidelines for health-economic evaluations in Austria]Evelyn Walter, Susanne Zehetmayr
Annals of Hematology|January 31, 2025
Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare systemEvelyn Walter, Francesca Torelli, Tiziano Barbui
Expert Review of Pharmacoeconomics & Outcomes Research|July 24, 2020
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patientsEvelyn Walter, Marco Voit, Gerald Eichhober
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 14, 2018
Introduction and OverviewEvelyn Walter
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 14, 2018
Approaches to Capturing Value in OncologyEvelyn Walter
Multiple Sclerosis and Related Disorders|April 21, 2015
Socio-economic aspects of the testing for antibodies in MS-patients under interferon therapy in Austria: a cost of illness studyEvelyn Walter, Florian Deisenhammer
Journal of Medical Economics|October 29, 2014
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and GermanyEvelyn Walter, Per Odin
Journal of Cardiothoracic and Vascular Anesthesia|December 16, 2019
Cost-Effectiveness Analysis of Landiolol, an Ultrashort-Acting Beta-Blocker, for Prevention of Postoperative Atrial Fibrillation for the Germany Health Care SystemEvelyn Walter, Matthias Heringlake
Wiener Medizinische Wochenschrift (1946)|January 11, 2007
[Theoretical implications of health economic evaluations in an Austrian context]Evelyn Walter, Susanne Zehetmayr
Wiener Medizinische Wochenschrift (1946)|May 27, 2008
[Cost of medications in the oncology sector in the context of health economics]Evelyn Walter, Anamarija Batista
Wiener Medizinische Wochenschrift (1946)|January 11, 2007
[Guidelines for health-economic evaluations in Austria]Evelyn Walter, Susanne Zehetmayr
Annals of Hematology|January 31, 2025
Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare systemEvelyn Walter, Francesca Torelli, Tiziano Barbui
Expert Review of Pharmacoeconomics & Outcomes Research|July 24, 2020
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patientsEvelyn Walter, Marco Voit, Gerald Eichhober
Pageof 3